Product Description
Mechanisms of Action: Voltage-Gated Potassium Channel Inhibitor
Novel Mechanism: Yes
Modality: Unknown
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
02/01/2023 |
PubMed |
Inactivation of potassium channels by ceramide in rat pancreatic Ī²-cells. |
|
08/01/2021 |
PubMed |
Clenbuterol-sensitive delayed outward potassium currents in a cell model of spinal and bulbar muscular atrophy. |